Quinalbarbitone (Na)

Quinalbarbitone (Na) is a hypnotic, belongs to barbiturates. Quinalbarbitone (Na) is used in the treatment of anxiety and insomnia.

Brands
Adult Dose
Dose: 0.71 to 2.86 mg/kg
Single Dose: 1.8 (1.785)
Frequency: 24 hourly
Route: PO
Instructions: As Required
Neonatal
Dose: Should not be used in children
Single Dose:
Frequency:
Route:
Instructions:
Paedriatic
Dose: Should not be used in children
Single Dose:
Frequency:
Route:
Instructions:
Characteristics
Quinalbarbitone (Na) also known as Secobarbital. . It is of Synthetic origin and belongs to Barbiturate. It belongs to Chloride Channel opener (Gaba operated) pharmacological group on the basis of mechanism of action and also classified in Sedatives and Hypnotics pharmacological group.The Molecular Weight of Quinalbarbitone (Na) is 260.30. Its pKa is 7.9.
Contraindications
Quinalbarbitone (Na) is contraindicated in conditions like Pain,Porphyrias.
Effects
The severe or irreversible adverse effects of Quinalbarbitone (Na), which give rise to further complications include Nystagmus, Respiratory depression, Myalgia, Neuralgia, Arthritic pain, Slurred speech, Somnolence, Semicoma, Shock.Quinalbarbitone (Na) produces potentially life-threatening effects which include Carcinogenicity, Unconsciousness. which are responsible for the discontinuation of Quinalbarbitone (Na) therapy.The signs and symptoms that are produced after the acute overdosage of Quinalbarbitone (Na) include Hypotension, Respiratory depression, Hypothermia, Miosis, Cardiodepression, Oliguria, Mydriasis.The symptomatic adverse reactions produced by Quinalbarbitone (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Ataxia, Restlessness, Confusion, VertigoX, Sedation, Euphoria.
Indications
Quinalbarbitone (Na) is primarily indicated in conditions like Insomnia.
Interactions
No data regarding the interactions of Quinalbarbitone (Na) was found.
Interfrence
Risks
Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Liver Malfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Cap, Elixir, Inj Protect from Sunlight.
Warnings
Avoid quinalbarbitone in patients with porphyria.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.